The phase 2 CAPTIVATE study: primary analysis of a fixed-duration cohort following first-line treatment with ibrutinib plus venetoclax for chronic lymphocytic leukemia/small lymphocytic lymphoma

Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair deficient solid tumors treated with dostarlimab

Patient Identification for Chimeric Antigen Receptor T-Cell Therapy: Initial Insights From the CARTITUDE Program in Multiple Myeloma

Effects of Niraparib on Health-Related Quality of Life in the Final Analysis of the GALAHAD Study in Patients With Metastatic Castration-Resistant Prostate Cancer and Homologous Recombination Repair Gene Alterations

What Can Patients With Prostate Cancer Expect From Treatment With Apalutamide? Health-Related Quality of Life in Patients With Metastatic Castration-Sensitive Prostate Cancer in the Phase 3 TITAN Study

Combination of darolutamide with androgen-deprivation therapy and docetaxel increases survival for patients with metastatic hormone-sensitive prostate cancer in the phase 3 ARASENS study

A phase 2 study evaluating the addition of ublituximab and umbralisib (U2) to ibrutinib in patients with chronic lymphocytic leukemia (CLL): a minimal residual disease (MRD)-driven, time-limited approach

Onset, duration, and management of edema and effusion in patients treated with loncastuximab tesirine for R/R DLBCL: updated results from the LOTIS-2 clinical trial

Characterization and Management of Cutaneous Reactions in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated with Loncastuximab Tesirine in the LOTIS-2 Trial

Safety outcomes of olaparib as maintenance therapy following first-line platinum-based chemotherapy for patients with BRCA-mutated metastatic pancreatic cancer: results from the POLO study

Nursing experience with patients receiving sotorasib for KRAS G12C-mutated solid tumors: follow-up from the phase 1/2 CodeBreaK 100 study

The Role of the Allied Health Professional in Pharmaceutical Advisory Boards: Identifying Educational Needs to Improve Care Delivery

Practical Guide for Infusion-related Reaction (IRR) Management with Amivantamab for Exon 20 Insertion Mutation (Ex20ins) Non-small Cell Lung Cancer (NSCLC): A Nurse's View

Association Between Declines in Prostate-Specific Antigen and Patient-Reported Outcomes in Patients With Advanced Prostate Cancer Treated With Apalutamide in the SPARTAN and TITAN Studies

Clinical Strategies for Mitigation of Cytokine Release Syndrome and Neurotoxicity With Chimeric Antigen Receptor T Cell Therapy Ciltacabtagene Autoleucel in Multiple Myeloma